Skip to content
OpenCapital
Get started

Regeneron Pharmaceuticals REGN EPS (Basic)

EPS (Basic) at other companies

Merck & Co. logo
Merck & Co.MRK
-$1.72-186%
Amgen logo
AmgenAMGN
$3.37+4.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$1.82+49.7%
Glaukos logo
GlaukosGKOS
-$0.34-6.3%
EyePoint, Inc. logo
EyePoint, Inc. EYPT
-$0.99-52.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$0.40-5.3%

Other financials

Income statement

See full
Revenue$3.6B+19.0%
Operating income$642.9M+8.7%
Net income$727.2M-10.1%
EPS (diluted)$6.75-7.2%

Balance sheet

See full
Cash & equivalents$3.0B-4.0%
Total debt$2.7B+0.1%
Total equity$31.4B+6.9%
Total assets$40.9B+8.9%

Cash flow

See full
Operating cash flow$1.1B+3.2%
CapEx$230.6M+0.6%
Free cash flow$848.3M+4.0%

Valuation

See full
Market cap$65.37B+16.2%
Enterprise value$65.11B+14.3%
P/E14.8×+2.2×
P/S4.4×+0.4×

Profitability

See full
Gross margin93.9%—
Operating margin24.3%-2.9pp
Net margin29.6%-2.3pp
FCF margin27.6%+5.5pp

Returns & leverage

See full
Return on equity14.5%-1.4pp
Debt / equity0.1×0.0×
Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regeneron Pharmaceuticals's EPS (basic)?
Regeneron Pharmaceuticals (REGN) reported EPS (basic) of $6.99 in Q1 2026.
How has Regeneron Pharmaceuticals's EPS (basic) changed year-over-year?
Regeneron Pharmaceuticals's EPS (basic) decreased by 7.8% year-over-year, from $7.58 to $6.99.
What is the long-term trend for Regeneron Pharmaceuticals's EPS (basic)?
Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's EPS (basic) has grown at a -13.3% compound annual growth rate (CAGR), from $76.44 to $43.15.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.